These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 2166096)

  • 1. Immunohistochemical study of lysozyme in various benign sweat apparatus tumors.
    Katsumata M; Ezoe K
    J Dermatol; 1990 May; 17(5):307-11. PubMed ID: 2166096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
    Mazoujian G
    Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoepithelial differentiation in benign sweat gland tumors. Demonstrated by a monoclonal antibody to alpha-smooth muscle actin.
    Eckert F; Betke M; Schmoeckel C; Neuweiler J; Schmid U
    J Cutan Pathol; 1992 Aug; 19(4):294-301. PubMed ID: 1331211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital papillated apocrine cystadenoma: a mixed form of hidrocystoma, hidradenoma papilliferum, and syringocystadenoma papilliferum.
    Schewach-Millet M; Trau H
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 2):374-6. PubMed ID: 6090513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
    Ansai S; Koseki S; Hozumi Y; Kondo S
    Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin.
    Mazoujian G; Margolis R
    Am J Dermatopathol; 1988 Feb; 10(1):28-35. PubMed ID: 2459984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual complex cutaneous adnexal tumor composed of syringocystadenoma papilliferum, apocrine hidrocystoma, and clear cell syringoma.
    Lin WL; Lin WC; Kuo TT; Chen CH; Hong HS
    Dermatol Surg; 2007 Jul; 33(7):876-9. PubMed ID: 17598859
    [No Abstract]   [Full Text] [Related]  

  • 8. Syringocystadenoma papilliferum combined with a tubular apocrine adenoma.
    Léda LDSB; Lins MDSVS; Leite EJDS; Cardoso AEC; Houly RLS
    An Bras Dermatol; 2017; 92(5):721-723. PubMed ID: 29166517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical studies of normal sweat glands, sweat gland tumors and extramammary Paget's diseases. II. Immunohistochemical studies of sweat gland tumors and extramammary Paget's diseases].
    Ansai S
    Nihon Hifuka Gakkai Zasshi; 1990 Feb; 100(2):133-46. PubMed ID: 2165191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staining of eccrine and apocrine neoplasms and metastatic adenocarcinoma with IKH-4, a monoclonal antibody specific for the eccrine gland.
    Ishihara M; Mehregan DR; Hashimoto K; Yotsumoto S; Toi Y; Pietruk T; Mehregan AH; Mehregan DA
    J Cutan Pathol; 1998 Feb; 25(2):100-5. PubMed ID: 9521499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of cytokeratin and vimentin intermediate filaments in benign and malignant sweat gland tumors.
    Eckert F; de Viragh PA; Schmid U
    J Cutan Pathol; 1994 Apr; 21(2):140-50. PubMed ID: 7518849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 distribution in sweat gland tumors suggests it has different functional roles in the various cell types.
    Fernández-Figueras MT; Puig L; Ariza A; Calatrava A; Fuente MJ; Ferrándiz C
    Am J Dermatopathol; 1996 Oct; 18(5):483-9. PubMed ID: 8902095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence and distribution of carcinoembryonic antigen and lectin-binding sites in benign apocrine sweat gland tumours.
    Tamaki K; Furue M; Matsukawa A; Ohara K; Mizoguchi M; Hino H
    Br J Dermatol; 1985 Nov; 113(5):565-71. PubMed ID: 2998432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of differentiation antigens in benign sweat gland tumours.
    Kariniemi AL; Forsman LM; Wahlström T; Andersson LC
    Br J Dermatol; 1984 Aug; 111(2):175-82. PubMed ID: 6380560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complex sweat gland tumor of the scalp. Association of a papillous syringocystadenoma and an apocrine hidrocystoma].
    Vittori F; Colomb D
    Arch Anat Cytol Pathol; 1976; 24(1):51-5. PubMed ID: 180909
    [No Abstract]   [Full Text] [Related]  

  • 16. Nevus comedonicus with hidradenoma papilliferum and syringocystadenoma papilliferum in the female genital area.
    Lee HJ; Chun EY; Kim YC; Lee MG
    Int J Dermatol; 2002 Dec; 41(12):933-6. PubMed ID: 12530358
    [No Abstract]   [Full Text] [Related]  

  • 17. Isoantigens A, B, H in normal skin and tumors of the epidermal appendages.
    England DM; Solie B; Winkelmann RK
    Arch Pathol Lab Med; 1979 Oct; 103(11):586-90. PubMed ID: 226027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor.
    Hsu PJ; Liu CH; Huang CJ
    J Cutan Pathol; 2003 Mar; 30(3):206-10. PubMed ID: 12641782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chondroid syringoma associated with hidrocystoma-like changes. Possible differentiation into eccrine gland. A histologic, immunohistochemical and electron microscopic study.
    Mihara M
    J Cutan Pathol; 1989 Oct; 16(5):281-6. PubMed ID: 2556458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of tubular apocrine adenoma with syringocystadenoma papilliferum.
    Ansai S; Watanabe S; Aso K
    J Cutan Pathol; 1989 Aug; 16(4):230-6. PubMed ID: 2551940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.